Skip to main navigation
Scientists Patients Medical Professionals Investors and Media Careers
 logo
  • News
  • Events
  • Stock
  • Financials
  • Governance
  • FAQs
    • Scientists
    • Patients
    • Medical Professionals
    • Investors and Media
    • Careers

INVESTORS & MEDIA

Financial Information

Financial Information
SEC Filings
Annual Reports and Proxy Statements
Quarterly Results

2022

  • Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
  • Regeneron Corporate Presentation February 2023 2.6 MB
  • Q4 2022 Earnings Conference Call Transcript 985.7 KB
  • Form 10-K
  • Regeneron Reports Third Quarter 2022 Financial and Operating Results
  • Regeneron Corporate Presentation November 2022 2.7 MB
  • Form 10-Q
  • Modeling Support: Post-Libtayo Transaction 818.9 KB
  • Regeneron Reports Second Quarter 2022 Financial and Operating Results
  • Form 10-Q
  • Regeneron Corporate Presentation August 2022 2.3 MB
  • Regeneron Reports First Quarter 2022 Financial and Operating Results
  • Form 10-Q
  • Regeneron Corporate Presentation May 2022 2.2 MB
  • Regeneron Reports Second Quarter 2022 Financial and Operating Results
  • Form 10-Q
  • Regeneron Corporate Presentation August 2022 2.3 MB

2021

  • Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
  • Form 10-K
  • Regeneron Corporate Presentation February 2022 1.6 MB
  • Regeneron Reports Third Quarter 2021 Financial and Operating Results
  • Form 10-Q
  • Regeneron Corporate Presentation November 2021 1.4 MB
  • Regeneron Reports Second Quarter 2021 Financial and Operating Results
  • Form 10-Q
  • Regeneron Corporate Presentation August 2021 1.6 MB
  • Regeneron Reports First Quarter 2021 Financial and Operating Results
  • Form 10-Q
  • Regeneron Corporate Presentation May 2021 1.5 MB

2020

  • Regeneron Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
  • Form 10-K
  • Regeneron Corporate Presentation February 2021 1.4 MB
  • Regeneron Reports Third Quarter 2020 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports Second Quarter 2020 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports First Quarter 2020 Financial and Operating Results
  • Form 10-Q

2019

  • Regeneron Reports Fourth Quarter and Full Year 2019 Financial and Operating Results 76.5 KB
  • Reconciliation of Additional Non-GAAP Financial Measures 15 KB
  • Form 10-K
  • Regeneron Reports Third Quarter 2019 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports Second Quarter 2019 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports First Quarter 2019 Financial and Operating Results
  • Form 10-Q

2018

  • Regeneron Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
  • Form 10-K
  • Regeneron Reports Third Quarter 2018 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports Second Quarter 2018 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports First Quarter 2018 Financial and Operating Results
  • Form 10-Q

2017

  • Regeneron Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
  • Form 10-K
  • Regeneron Reports Third Quarter 2017 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports Second Quarter 2017 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports First Quarter 2017 Financial and Operating Results
  • Form 10-Q

2016

  • Regeneron Reports Fourth Quarter and Full Year 2016 Financial and Operating Results
  • Form 10-K
  • Regeneron Reports Third Quarter 2016 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports Second Quarter 2016 Financial and Operating Results
  • Form 10-Q
  • Regeneron Reports First Quarter 2016 Financial and Operating Results
  • Form 10-Q
Email Alerts
RSS Newsfeed
Share This Page
Search
Regeneron logo
  • Twitter logo
  • LinkedIn logo
  • Facebook logo
  • Instagram logo
  • YouTube logo
  • Terms of Use
  • Contact Us
  • Site Map
  • Social Media Terms of Engagement
  • Privacy Notice
  • Accessibility Statement
  • Investors and Media
  • Careers
  • Ireland
  • Covid-19 Antibody Program

Copyright © 2023 Regeneron Pharmaceuticals Inc. All rights reserved. All trademarks mentioned are the property of their respective owners.

Back to top

Investors & Media

  • Facebook
  • LinkedIn
  • Twitter
  • RSS Feeds

You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

Continue

You are now leaving Regeneron.com to visit another Regeneron pharmaceuticals website.

Continue